Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Small Cell Lung Cancer Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06567015
What this trial is testing

Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Pierre Fabre Medicament 171
Testing effectiveness (Phase 2)Ended earlyNCT05500508
What this trial is testing

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Who this might be right for
CancerSolid TumorSolid Carcinoma+17 more
Aminex Therapeutics, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00890825
What this trial is testing

AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC Patients

Who this might be right for
Non Small Cell Lung Cancer
AstraZeneca 88
Testing effectiveness (Phase 2)Study completedNCT00326599
What this trial is testing

Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 101
Large-scale testing (Phase 3)Not Yet RecruitingNCT07361484
What this trial is testing

Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)

Who this might be right for
Non-Small Cell Lung CancerNon-squamous Non-Small Cell Lung Cance
BeyondSpring Pharmaceuticals Inc. 442
Large-scale testing (Phase 3)Looking for participantsNCT06881784
What this trial is testing

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)Non-Small Cell Lung CancerNSCLC+2 more
Revolution Medicines, Inc. 590
Testing effectiveness (Phase 2)Active Not RecruitingNCT06710132
What this trial is testing

Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

Who this might be right for
Solid TumorsGastric CancerNon-Small Cell Lung Cancer (NSCLC)+2 more
EMD Serono Research & Development Institute, Inc. 184
Testing effectiveness (Phase 2)Ended earlyNCT00281021
What this trial is testing

Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
University of Louisville 26
Early research (Phase 1)Study completedNCT07504484
What this trial is testing

Safety and Efficacy of Neoantigen-Based Personalized Immunotherapy as Consolidation Therapy After Standard Adjuvant Treatment in Resectable Stage III Colorectal Cancer or Non-Small Cell Lung Cancer

Who this might be right for
CRC (Colorectal Cancer)Non Small Lung Cancer
Ying Yuan, MD 6
Early research (Phase 1)Study completedNCT04052971
What this trial is testing

To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET Dysregulation

Who this might be right for
Advanced Solid Tumors
Abion Inc 24
Testing effectiveness (Phase 2)Study completedNCT01037998
What this trial is testing

UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
Taipei Veterans General Hospital, Taiwan 115
Testing effectiveness (Phase 2)Study completedNCT00230126
What this trial is testing

OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Ohio State University Comprehensive Cancer Center 57
Testing effectiveness (Phase 2)Looking for participantsNCT07122687
What this trial is testing

IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 170
Testing effectiveness (Phase 2)UnknownNCT05117658
What this trial is testing

Study of HA121-28 in Patients With Non-Small Cell Lung Cancer

Who this might be right for
NSCLC
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 83
Not applicableUnknownNCT03566576
What this trial is testing

Phase I Study of the Combination of Anlotinib With Pemetrexed or Docetaxel

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Fujian Cancer Hospital 18
Early research (Phase 1)Study completedNCT01933568
What this trial is testing

Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm.

Who this might be right for
Inoperable Locally Advanced Non Small Cell Lung Cancer
The Netherlands Cancer Institute 15
Early research (Phase 1)UnknownNCT00497250
What this trial is testing

Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Fudan University 32
Post-approval studies (Phase 4)Study completedNCT01196078
What this trial is testing

Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 114
Testing effectiveness (Phase 2)Study completedNCT01059643
What this trial is testing

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Ovarian CancerNon Small Cell Lung CancerProstate Cancer+4 more
Eli Lilly and Company 103
Testing effectiveness (Phase 2)Looking for participantsNCT06667908
What this trial is testing

JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Johnson & Johnson Enterprise Innovation Inc. 130
Next Page